#BEGIN_DRUGCARD DB04519

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
124-07-2

# ChEBI_ID:
28837

# Chemical_Formula:
C8H16O2

# Chemical_IUPAC_Name:
octanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Caprylic acid is the common name for the eight-carbon straight chain fatty acid known by the systematic name octanoic acid. It is found naturally in coconuts and breast milk. It is an oily liquid with a slightly unpleasant rancid-like smell that is minimally soluble in water.

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
3.05

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
789 mg/L (at 30 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Caprylic acid

# HET_ID:
OCA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H16O2/c1-2-3-4-5-6-7-8(9)10/h2-7H2,1H3,(H,9,10)

# InChI_Key:
InChIKey=WWZKQHOCKIZLMA-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C06423

# KEGG_Drug_ID:
D05220

# LIMS_Drug_ID:
4519

# Mechanism_Of_Action:
Not Available

# Melting_Point:
16.3 °C

# Molecular_Weight_Avg:
144.2114

# Molecular_Weight_Mono:
144.115029756

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1OG9

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.92

# Predicted_LogS:
-2.2

# Predicted_Water_Solubility:
9.07e-01 g/l

# Primary_Accession_No:
DB04519

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
379

# PubChem_Substance_ID:
46507647

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02413

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCCCCCC(O)=O

# State:
liquid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Caprylsaeure
Enantic acid
Kaprylsaeure
Octic acid
Octylic acid
capryloate
n-Octoic acid
n-caprylic acid
n-octanoic acid
n-octylic acid
neo-fat 8
octanoate
octanoic acid
octoic acid

# Synthesis_Reference:
Not Available

# Toxicity:
Oral rat LD<sub>50</sub>: 10080 mg/kg. Intravenous mouse LD<sub>50</sub>: 600 mg/kg. Skin rabbit LD<sub>50</sub>: over 5000 mg/kg.

# Update_Date:
2013-02-08 16:23:25 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Caprylic_acid

# pKa_Isoelectric_Point:
4.89 (at 25 °C)

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M24427

# Drug_Target_1_GenBank_ID_Protein:
145884

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
fabB

# Drug_Target_1_Gene_Sequence:
>1221 bp
ATGAAACGTGCAGTGATTACTGGCCTGGGCATTGTTTCCAGCATCGGTAATAACCAGCAG
GAAGTCCTGGCATCTCTGCGTGAAGGACGTTCAGGGATCACTTTCTCTCAGGAGCTGAAG
GATTCCGGCATGCGTAGCCACGTCTGGGGCAACGTAAAACTGGATACCACTGGCCTCATT
GACCGCAAAGTTGTGCGCTTTATGAGCGACGCATCCATTTATGCATTCCTTTCTATGGAG
CAGGCAATCGCTGATGCGGGCCTCTCTCCGGAAGCTTACCAGAATAACCCGCGCGTTGGC
CTGATTGCAGGTTCCGGCGGCGGCTCCCCGCGTTTCCAGGTGTTCGGCGCTGACGCAATG
CGCGGCCCGCGCGGCCTGAAAGCGGTTGGCCCGTATGTGGTCACCAAAGCGATGGCATCC
GGCGTTTCTGCCTGCCTCGCCACCCCGTTTAAAATTCATGGCGTTAACTACTCCATCAGC
TCCGCGTGTGCGACTTCCGCACACTGTATCGGTAACGCAGTAGAGCAGATCCAACTGGGC
AAACAGGACATCGTGTTTGCTGGCGGCGGCGAAGAGCTGTGCTGGGAAATGGCTTGCGAA
TTCGACGCAATGGGTGCGCTGTCTACTAAATACAACGACACCCCGGAAAAAGCCTCCCGT
ACTTACGACGCTCACCGTGACGGTTTCGTTATCGCTGGCGGCGGCGGTATGGTAGTGGTT
GAAGAGCTGGAACACGCGCTGGCGCGTGGTGCTCACATCTATGCTGAAATCGTTGGCTAC
GGCGCAACCTCTGATGGTGCAGACATGGTTGCTCCGTCTGGCGAAGGCGCAGTACGCTGC
ATGAAGATGGCGATGCATGGCGTTGATACCCCAATCGATTACCTGAACTCCCACGGTACT
TCGACTCCGGTTGGCGACGTGAAAGAGCTGGCAGCTATCCGTGAAGTGTTCGGCGATAAG
AGCCCGGCGATTTCTGCAACCAAAGCCATGACCGGTCACTCTCTGGGCGCTGCTGGCGTA
CAGGAAGCTATCTACTCTCTGCTGATGCTGGAACACGGCTTCATCGCCCCGAGCATCAAC
ATTGAAGAGCTGGACGAGCAGGCTGCAGGTCTGAACATCGTGACCGAAACGACCGATCGC
GAACTGACCACCGTTATGTCTAACAGCTTCGGCTTCGGCGGCACCAACGCCACGCTGGTA
ATGCGCAAGCTGAAAGATTAA

# Drug_Target_1_General_Function:
Lipid transport and metabolism

# Drug_Target_1_General_References:
10571059	Olsen JG, Kadziola A, von Wettstein-Knowles P, Siggaard-Andersen M, Lindquist Y, Larsen S: The X-ray crystal structure of beta-ketoacyl [acyl carrier protein] synthase I. FEBS Lett. 1999 Oct 22;460(1):46-52.
3076376	Kauppinen S, Siggaard-Andersen M, von Wettstein-Knowles P: beta-Ketoacyl-ACP synthase I of Escherichia coli: nucleotide sequence of the fabB gene and identification of the cerulenin binding residue. Carlsberg Res Commun. 1988;53(6):357-70.
3076377	Siggaard-Andersen M: Role of Escherichia coli beta-ketoacyl-ACP synthase I in unsaturated fatty acid synthesis. Carlsberg Res Commun. 1988;53(6):371-9.
9205837	Yamamoto Y, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kimura S, Kitagawa M, Makino K, Miki T, Mitsuhashi N, Mizobuchi K, Mori H, Nakade S, Nakamura Y, Nashimoto H, Oshima T, Oyama S, Saito N, Sampei G, Satoh Y, Sivasundaram S, Tagami H, Horiuchi T, et al.: Construction of a contiguous 874-kb sequence of the Escherichia coli -K12 genome corresponding to 50.0-68.8 min on the linkage map and analysis of its sequence features. DNA Res. 1997 Apr 28;4(2):91-113.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
889

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
42614

# Drug_Target_1_Name:
3-oxoacyl-[acyl-carrier-protein] synthase 1

# Drug_Target_1_Number_of_Residues:
406

# Drug_Target_1_PDB_ID:
1G5X

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00109	ketoacyl-synt
PF02801	Ketoacyl-synt_C

# Drug_Target_1_Protein_Sequence:
>3-oxoacyl-[acyl-carrier-protein] synthase 1
MKRAVITGLGIVSSIGNNQQEVLASLREGRSGITFSQELKDSGMRSHVWGNVKLDTTGLI
DRKVVRFMSDASIYAFLSMEQAIADAGLSPEAYQNNPRVGLIAGSGGGSPRFQVFGADAM
RGPRGLKAVGPYVVTKAMASGVSACLATPFKIHGVNYSISSACATSAHCIGNAVEQIQLG
KQDIVFAGGGEELCWEMACEFDAMGALSTKYNDTPEKASRTYDAHRDGFVIAGGGGMVVV
EELEHALARGAHIYAEIVGYGATSDGADMVAPSGEGAVRCMKMAMHGVDTPIDYLNSHGT
STPVGDVKELAAIREVFGDKSPAISATKAMTGHSLGAAGVQEAIYSLLMLEHGFIAPSIN
IEELDEQAAGLNIVTETTDRELTTVMSNSFGFGGTNATLVMRKLKD

# Drug_Target_1_Reaction:
an acyl-[acyl-carrier-protein] + malonyl-[acyl-carrier-protein] = a 3-oxoacyl-[acyl-carrier-protein] + CO2 + [acyl-carrier-protein]

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. Specific for elongation from C-10 to unsaturated C-16 and C-18 fatty acids

# Drug_Target_1_SwissProt_ID:
P0A953

# Drug_Target_1_SwissProt_Name:
FABB_ECOLI

# Drug_Target_1_Synonyms:
3-oxoacyl- [acyl-carrier-protein] synthase I
Beta-ketoacyl-ACP synthase I
EC 2.3.1.41
KAS I

# Drug_Target_1_Theoretical_pI:
5.25

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Periplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
L06182

# Drug_Target_2_GenBank_ID_Protein:
290474

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
tesA

# Drug_Target_2_Gene_Sequence:
>627 bp
ATGATGAACTTCAACAATGTTTTCCGCTGGCATTTGCCCTTCCTGTTCCTGGTCCTGTTA
ACCTTCCGTGCCGCCGCAGCGGACACGTTATTGATTCTGGGTGATAGCCTGAGCGCCGGG
TATCGAATGTCTGCCAGCGCGGCCTGGCCTGCCTTGTTGAATGATAAGTGGCAGAGTAAA
ACGTCGGTAGTTAATGCCAGCATCAGCGGCGACACCTCGCAACAAGGACTGGCGCGCCTT
CCGGCTCTGCTGAAACAGCATCAGCCGCGTTGGGTGCTGGTTGAACTGGGCGGCAATGAC
GGTTTGCGTGGTTTTCAGCCACAGCAAACCGAGCAAACGCTGCGCCAGATTTTGCAGGAT
GTCAAAGCCGCCAACGCTGAACCATTGTTAATGCAAATACGTCTGCCTGCAAACTATGGT
CGCCGTTATAATGAAGCCTTTAGCGCCATTTACCCCAAACTCGCCAAAGAGTTTGATGTT
CCGCTGCTGCCCTTTTTTATGGAAGAGGTCTACCTCAAGCCACAATGGATGCAGGATGAC
GGTATTCATCCCAACCGCGACGCCCAGCCGTTTATTGCCGACTGGATGGCGAAGCAGTTG
CAGCCTTTAGTAAATCATGACTCATAA

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
1864840	Karasawa K, Kudo I, Kobayashi T, Homma H, Chiba N, Mizushima H, Inoue K, Nojima S: Lysophospholipase L1 from Escherichia coli K-12 overproducer. J Biochem (Tokyo). 1991 Feb;109(2):288-93.
8098033	Cho H, Cronan JE Jr: Escherichia coli thioesterase I, molecular cloning and sequencing of the structural gene and identification as a periplasmic enzyme. J Biol Chem. 1993 May 5;268(13):9238-45.
8432696	Ichihara S, Matsubara Y, Kato C, Akasaka K, Mizushima S: Molecular cloning, sequencing, and mapping of the gene encoding protease I and characterization of proteinase and proteinase-defective Escherichia coli mutants. J Bacteriol. 1993 Feb;175(4):1032-7.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3686

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
23622

# Drug_Target_2_Name:
Acyl-CoA thioesterase I precursor

# Drug_Target_2_Number_of_Residues:
208

# Drug_Target_2_PDB_ID:
1U8U

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00657	Lipase_GDSL

# Drug_Target_2_Protein_Sequence:
>Acyl-CoA thioesterase I precursor
MMNFNNVFRWHLPFLFLVLLTFRAAAADTLLILGDSLSAGYRMSASAAWPALLNDKWQSK
TSVVNASISGDTSQQGLARLPALLKQHQPRWVLVELGGNDGLRGFQPQQTEQTLRQILQD
VKAANAEPLLMQIRLPANYGRRYNEAFSAIYPKLAKEFDVPLLPFFMEEVYLKPQWMQDD
GIHPNRDAQPFIADWMAKQLQPLVNHDS

# Drug_Target_2_Reaction:
2-lysophosphatidylcholine + H2O = glycerophosphocholine + a carboxylate

# Drug_Target_2_Signals:
1-26

# Drug_Target_2_Specific_Function:
Hydrolyzes only long chain acyl thioesters (C12-C18). Specificity similar to chymotrypsin

# Drug_Target_2_SwissProt_ID:
P0ADA1

# Drug_Target_2_SwissProt_Name:
TESA_ECOLI

# Drug_Target_2_Synonyms:
EC 3.1.1.5
EC 3.1.2.-
Lecithinase B
Lysophospholipase L1
Protease I

# Drug_Target_2_Theoretical_pI:
7.83

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04519
